News Antares to develop injector pen drug with Pfizer New Jersey based Antares has signed a deal with pharma giant Pfizer to develop an auto injector pen for an undisclosed Pfizer drug, adding 13% to its shares value on Nasdaq.
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face